Bipolar Disorder
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
We found that SNPs in the AKAP10 and PRKCI genes are significantly associated with bipolar disorder and gene expression variation.
|
21382426 |
2011 |
Bipolar Disorder
|
0.320 |
Biomarker
|
disease |
BEFREE |
Even though the glutamatergic and HPA pathways may not be involved in BD-AUD and BD-SUD comorbidity, PRKCI deserves further investigation in BD-AUD.
|
26563126 |
2016 |
Bipolar Disorder
|
0.320 |
Biomarker
|
disease |
PSYGENET |
Postmortem studies identified PKCI/HINT1 as a candidate molecule for schizophrenia and bipolar disorder.
|
19912621 |
2009 |
Bipolar Disorder
|
0.320 |
Biomarker
|
disease |
PSYGENET |
We found that SNPs in the AKAP10 and PRKCI genes are significantly associated with bipolar disorder and gene expression variation.
|
21382426 |
2011 |
Mental Depression
|
0.300 |
Biomarker
|
disease |
PSYGENET |
Contribution of cerebellar sensorimotor adaptation to hippocampal spatial memory.
|
22485133 |
2012 |
Depressive disorder
|
0.300 |
Biomarker
|
disease |
PSYGENET |
Contribution of cerebellar sensorimotor adaptation to hippocampal spatial memory.
|
22485133 |
2012 |
Metastatic melanoma
|
0.300 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Diabetes Mellitus, Experimental
|
0.200 |
Biomarker
|
disease |
RGD |
Protein kinase C modulation of the regulation of sarcoplasmic reticular function by protein kinase A-mediated phospholamban phosphorylation in diabetic rats.
|
14691046 |
2004 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
Obesity
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
Abdominal obesity metabolic syndrome
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
Prostate carcinoma
|
0.130 |
Biomarker
|
disease |
BEFREE |
Larger studies with multiethnic groups are warranted to confirm these findings and to explore the role of PRKCI SNPs in the etiology of PCa.
|
24510606 |
2015 |
Prostate carcinoma
|
0.130 |
GeneticVariation
|
disease |
BEFREE |
Our findings showed that rs546950 polymorphism of PRKCI decreased the risk of PCa in codominant (OR=0.35, 95%CI=0.19-0.64, P<0.001, CT vs CC) and dominant (OR=0.39, 95%CI=0.22-0.69, P=0.001, CT+TT vs CC) inheritance model tested.
|
26475383 |
2015 |
Prostate carcinoma
|
0.130 |
GeneticVariation
|
disease |
GWASCAT |
Two susceptibility loci identified for prostate cancer aggressiveness.
|
25939597 |
2015 |
Prostate carcinoma
|
0.130 |
AlteredExpression
|
disease |
BEFREE |
In conclusion, we found an association with prostate cancer risk for two SNPs belonging to PRKCI, a gene which is frequently overexpressed in various neoplasms, including prostate cancer.
|
21373201 |
2011 |
Glioblastoma
|
0.050 |
Biomarker
|
disease |
LHGDN |
Regulation of glioblastoma cell invasion by PKC iota and RhoB.
|
18212741 |
2008 |
Glioblastoma
|
0.050 |
Biomarker
|
disease |
BEFREE |
Previously, we have shown that protein kinase C iota (PKCι) depletion induces cellular senescence in glioblastoma cells in the absence of a detectable DNA damage response.
|
26208522 |
2015 |
Glioblastoma
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
This phenomenon was not restricted to breast cancer cells, as it was also seen in glioblastoma cells in which PKCι is activated by loss of PTEN.
|
22120720 |
2012 |
Glioblastoma
|
0.050 |
Biomarker
|
disease |
BEFREE |
In a previous study, Protein Kinase C iota (PRKCI) emerged as an important candidate gene for glioblastoma (GBM) stem-like cell (GSC) survival.
|
27299852 |
2016 |
Glioblastoma
|
0.050 |
Biomarker
|
disease |
BEFREE |
The focus of this research was to investigate the role of protein kinase C-iota (PKC-ι) in regulation of Bad, a pro-apoptotic BH3-only molecule of the Bcl-2 family in glioblastoma.
|
21419810 |
2011 |
Glioma
|
0.040 |
Biomarker
|
disease |
LHGDN |
Cyclin-dependent kinase activating kinase/Cdk7 co-localizes with PKC-iota in human glioma cells.
|
15695176 |
2005 |
Glioma
|
0.040 |
Biomarker
|
disease |
BEFREE |
Since, PKC-ι is an essential downstream mediator of the PI (3)-kinase, we hypothesize that glioma cell survival is mediated via a PI (3)-kinase/PDK1/PKC-ι/Bad pathway.
|
21419810 |
2011 |
Glioma
|
0.040 |
Biomarker
|
disease |
BEFREE |
Circular RNA PRKCI promotes glioma cell progression by inhibiting microRNA-545.
|
31409777 |
2019 |
Glioma
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
Protein kinase C-iota (PKC-ι) is an oncogene overexpressed in many cancer cells including prostate, breast, ovarian, melanoma, and glioma.
|
30204596 |
2019 |
ovarian neoplasm
|
0.040 |
Biomarker
|
disease |
BEFREE |
The PRKCI-YAP1 regulation of the tumor immunity provides a therapeutic strategy for highly lethal ovarian cancer.
|
28698296 |
2017 |